When suffering from high blood pressure, many patients turn to medication to treat their conditions. Since its initial approval for commercial use in 2002, Benicar has been one of the most widely prescribed drugs designed to treat high blood pressure. Unfortunately, studies have now shown a link between the use of this drug and certain severe gastrointestinal issues. Many patients suffering from villous atrophy after using Benicar are now filing lawsuits as a result.
Five Tips About the Benicar Lawsuits Associated With Villous Atrophy
The following is an overview of the lawsuits relating to Benicar use and villous atrophy:
- Lawsuits are being filed against the drug’s distributors, Daiichi Sankyo and Forest Laboratories.
- Many of these lawsuits are product liability lawsuits.
- The lawsuits are brought by individuals who have taking Benicar to treat their high blood pressure and suffered severe and debilitating gastrointestinal injuries as a result.
- The plaintiffs in these lawsuits allege that the drug makers knew or should have known about the risks associated with taking Benicar.
- In addition, the plaintiffs accuse the drug makers of failing to provide consumers with adequate warnings. They allege that had they been properly warned, they would have sought medical attention upon experiencing diarrhea or other gastrointestinal symptoms. Had they sought this treatment, they may have avoided long-term gastrointestinal damage associated with villous atrophy as a result of taking Benicar.
The issue of the lack of warnings surrounding Benicar use is a serious one. Many of the problems associated with Benicar use are initially misdiagnosed as another condition, including Celiac disease. When these misdiagnoses occur, effective treatment for the patient is delayed.
If you or a loved one suffered adverse side effects after taking Benicar, it is important to act quickly to protect your legal rights. We encourage you to contact us today for a consultation at 888-526-7616.
|
Related Links:
|